Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Nursing Activities for High Complexity Oncologic Care Patients

28. juli 2016 opdateret af: Amelia Palinuro, Catholic University of the Sacred Heart

Quantifying and Measuring the Economic Impact of Nursing Activities During the Hospital Stay of High Complexity Oncologic Care Patients

the study consists of an observational study aimed at quantifying the economic burden of the nursing activities on the overall cost of hospitalizations funded through DRG tariffs for Major complexity oncology patients.

Studieoversigt

Status

Ukendt

Betingelser

Detaljeret beskrivelse

Study design

The methodological approach used to achieve the objective of this research is quantitative. A mixed study design is being adopted:

  1. Retrospective study to determine the nature and volume of activity provided at nursing classes of patients whose admission is attributed to a specific DRG
  2. Longitudinal prospective study to determine the variability of costs of nurses with regard to DRG refund, comparatively to distribution of patients for every single section (high, medium, low complexity).

Study population The sample has been chosen considering the prevalence of hospitalizations per year in medical oncology U.O.C. related to certain DRG and characterized by greater complexity of care, so as to provide a useful information base for study. For the retrospective study the survey will be conducted on a sample of 150 patients. Patients will be enrolled at high, medium and low complexity of care, hospitalized for chemotherapy and for biliary obstructive urinary tract and in the first half of 2016. It is estimated that the sample represents 30% of the total number of admissions made in 2016. A prospective longitudinal study will take into consideration a sample of 150 patients with the same characteristics considered for enrollment in the retrospective study.

The study will include patients who under go: CHT with a duration of hospital stay of 2-3 days (microcitomi and NHL), CHT with a length of hospital stay of 4-5 days (sarcomas), CHT with a length of hospital stay > 5 days or at high doses (testicle cancer, Ewing's sarcoma and bone sarcoma) and patients with higher complexity care.

Patients of 18 years of age or less will be excluded, as well as patients that were transferred to other units while inpatient, patients transferred in U.O.C. of Oncology after major surgery procedures in other departments, and admissions that are outliers.

The duration for the monitoring phase on the allocation and the distribution of patients among the different sections of hospital care intensity (Intensità di cure, IC) and care complexity (Complessità Assistenziale, CA), based on the results obtained by the Triage of corridor (TriCO), is estimated for 3 months up to a maximum of six months starting from March 2016. For the collection of data relating to the amount and types of activities provided in the first half of 2016 is estimated to have a maximum of 30 days and others 30 days for the detection the relative DRG reimbursed for hospitalizations considered.

Survey instruments

  • Professional Assessment Instrument (PAI). It is a tool that documents nursing processes implemented in a computerized way using nursing language according to the North American Nursing Diagnosis Association International (NANDA-I).
  • Hospital discharge card (Scheda di dimissione ospedaliera, SDO). It is a tool that contains information about each patient discharged, that are necessary for the attribution to DRG and for finding the rate payable for each episode of hospitalization
  • Scheda di mobilità interna dei pazienti. It is a card that contains data of Tri-CO at the entrance of the patient and any variations of that index during hospitalization.

Interventions The study will be presented to the manager and coordinator of the U.O.C. Medical Oncology through a moment of training/information.

In order to collect data on the variation of Tri-CO during hospitalization, and consequently the different allocation to U.O.C. of Oncology of patients in sections of low, medium and high complexity of care, a point of contact (nurse) will be identified who will deal with the collection and retention of such information in the manner set out in the research protocol.

Outcome measures

The primary outcome expected by the survey is the quantification of the volume of nursing activities provided to patients and its cost. In addition, we expect to realize economic indicators which make it possible to ascertain:

  • Cost weight of the nursing staff on the DRG rate reimbursed in relation to the complexity care of the patient;
  • Cost weight of the nursing staff on the reimbursement for hospitalization in connection with the DRG of patient discharge.
  • Gap between theoretical and actual cost of nurses in relation to the care delivered for a specific patient; Knowledge of actual costs for each distinct and specific episode of hospitalization would enhance its "uniqueness". An economic analysis of labor nursing costs for individual patient could provide input for the determination of the costs of all the professionals of the Foundation, contributing to the improvement of corporate strategic management for resource allocation.

Statistical analysis Statistical analyses will be performed using methods of descriptive statistics and inferential statistics appropriate to the sample size and study variables. Prospective longitudinal study will be used to determine the frequency distribution and the variance on the stay of the patients in each individual section of hospital in-patient treatment which is attributed to a specific DRG. Then a factorial analysis and regression techniques will be used to measure the type of bond that exists between the dependent variable Y (nursing) and independent variables X1, X2, X3 ... (DRG, age, days of hospitalization, complications, etc). Then the analysis will continue by studying which variables will affect the distribution of patients for IC and CA level and how it can change this assignment during a single in-patient episode, creating a variability in costs of services paid.

Undersøgelsestype

Observationel

Tilmelding (Forventet)

300

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

The sample has been chosen considering the prevalence of hospitalizations per year in medical oncology U.O.C. related to certain DRG and characterized by greater complexity of care, so as to provide a useful information base for study. For the retrospective study the survey will be conducted on a sample of 150 patients. Patients will be enrolled at high, medium and low complexity of care, hospitalized for chemotherapy and for biliary obstructive urinary tract and in the first half of 2016.

Beskrivelse

Inclusion Criteria:

  • CHT with a duration of hospital stay of 2-3 days (microcitomi and NHL),
  • CHT with a length of hospital stay of 4-5 days (sarcomas),
  • CHT with a length of hospital stay > 5 days (in case of high doses: testicle cancer, Ewing's sarcoma and bone sarcoma)
  • Oncologic patients with higher complexity care.

Exclusion Criteria:

  • Patients of 18 years of age or less
  • Patients transferred to other units while inpatient
  • Patients transferred in U.O.C. of Oncology after major surgery procedures in other departments
  • Outlier admissions

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Retrospective cohort
150 oncologic patients belonging to major complexity DRGs
Perspective cohort
150 oncologic patients belonging to major complexity DRGs

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Volume of Nursing Activity
Tidsramme: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
Count of nusing activities performed to patients in different complexity groups
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cost weight of the nursing staff on the DRG rate reimbursed in relation to the complexity care (Complessità Assistenziale, CA) of the patient.
Tidsramme: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
Cost weight of the nursing staff on the DRG rate reimbursed in relation to the complexity care of the patient
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
Cost weight of the nursing staff on the reimbursement for hospitalization in connection with the DRG of patient discharge
Tidsramme: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
Cost weight of the nursing staff on the reimbursement for hospitalization in connection with the DRG of patient discharge.
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
Mean difference between theoretical and actual cost of nurses in relation to the care delivered for a specific patient.
Tidsramme: Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.
Difference between theoretical and actual cost of nurses in relation to the care delivered for a specific patient. The nursing time cost expressed in minutes results from the standard cost for each nursing hour worked by a nurse. The time in minutes of the performance is detected by the time indicated on standard nursing protocols considered for the study. The time in minutes of a benefit provided to specific types of patients considered comes from the average execution time of nursing care.
Through study completion, based on the patients' discharge date. The first outcome assessments are expected in December 2016.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. februar 2016

Primær færdiggørelse (Forventet)

1. februar 2017

Studieafslutning (Forventet)

1. maj 2017

Datoer for studieregistrering

Først indsendt

13. juli 2016

Først indsendt, der opfyldte QC-kriterier

22. juli 2016

Først opslået (Skøn)

27. juli 2016

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

29. juli 2016

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

28. juli 2016

Sidst verificeret

1. juli 2016

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • FAG14

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

3
Abonner